Robeco Institutional Asset Management
LEGN icon

Robeco Institutional Asset Management’s Legend Biotech LEGN Stock Holding History

Robeco Institutional Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,903
Closed -$128K – 1118
2023
Q3 		$128K Hold
1,903
– – ﹤0.01% 949
2023
Q2 		$131K Sell
1,903
-787
-29% -$51.4K ﹤0.01% 963
2023
Q1 		$130K Sell
2,690
-77,808
-97% -$3.81M ﹤0.01% 966
2022
Q4 		$4.02M Buy
+80,498
New +$3.9M 0.01% 599
2020
Q3 		– Sell
-618
Closed -$26K – 962
2020
Q2 		$26K Buy
+618
New +$24.1K ﹤0.01% 951

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Robeco Institutional Asset Management's LEGN Position: Q4 2023 in Review

Robeco Institutional Asset Management sold out of Legend Biotech (LEGN) in Q4 2023, closing a stake of 1,903 shares — an estimated $128K sold.

Robeco Institutional Asset Management first reported a position in LEGN in Q2 2020 and held it in 5 quarters. The position peaked at $4.02M in Q4 2022. 206 funds tracked by Wall St. Rank hold LEGN as of Q4 2023.

  • Robeco Institutional Asset Management reported no remaining Legend Biotech position as of Q4 2023 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 1,903 Legend Biotech shares in Q4 2023, an estimated $128K.
  • Robeco Institutional Asset Management first reported a position in Legend Biotech in Q2 2020 and held it in 5 quarters.
  • Robeco Institutional Asset Management's Legend Biotech position peaked at $4.02M in Q4 2022.
  • 206 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2023.

Based on Robeco Institutional Asset Management's 13F filing for Q4 2023, filed 8 Feb 2024.